MedPath

Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention

Not Applicable
Completed
Conditions
Drug Use Disorders
Interventions
Behavioral: TAU plus Control Tasks
Behavioral: TAU plus Cognitive Remediation Program
Registration Number
NCT03373240
Lead Sponsor
Yale University
Brief Summary

We are proposing a small randomized clinical trial in which 100 substance users will complete the existing Psychotherapy Development Center (PDC) pretreatment assessment battery as well as a novel battery of assays to evaluate cognitive-affective functioning. After completing pretreatment assessments, participants will be randomized to either a (1) cognitive remediation program (training tasks) specifically designed to address cognitive-affective dysregulation or (2) control tasks (verbal fluency tasks). Tasks will be completed twice per week for 4 weeks, after which assessment batteries will be repeated. Finally, we will evaluate real-world behavior and the durability of the training via a one-month follow-up, which will include assessment of substance use as well as the cognitive-affective battery.

Detailed Description

Participants will be 100 individuals (aged 18 to 50) enrolled in outpatient (non- methadone/buprenorphine) treatment for any substance use disorder (other than PCP) at the Substance Abuse Treatment Unit in New Haven. As the goal of this project is to develop interventions that address self-regulation across multiple disorders, we will recruit individuals who have a range of substance use disorders and levels of severity. Our primary Specific Aim will be to evaluate the efficacy of the cognitive-remediation program relative to the control condition control on the indicators of cognitive-affective functioning and substance use, testing the hypothesis that individuals randomized to the cognitive remediation program will demonstrate improved functioning on the cognitive-affective battery as well as reduced real-world substance abuse. We will also explore potential moderators of response to the training, including baseline measures of cognitive-affective function.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Meet current DSM-5 criteria for an alcohol, stimulant, cannabis, or opioid use disorder.
  • Are sufficiently stable for 4 weeks of outpatient treatment.
  • Are willing to provide locator information.
  • Are fluent in English and have a 4th grader or higher reading level
Exclusion Criteria
  • Meet DSM-5 criteria for a bipolar or schizophrenic disorder.
  • Who have a legal case pending such that incarceration during the 4-week protocol is likely.
  • Are physically dependent on alcohol, opioids or benzodiazepines or who report recent PCP use.
  • Have a baseline Shipley estimated IQ less than 70
  • Have 3 or more head injuries with loss of consciousness for over 30 minutes or lasting effects
  • Have a history of chronic illness or neurological disorders (e.g., epilepsy or stroke) that would complicate evaluation of effects of cognitive training

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TAU plus Control TasksTAU plus Control TasksTreatment normally received at this clinic that generally includes individual or group sessions and regular urine monitoring PLUS a series of computerized word games.
TAU plus Cognitive Remediation ProgramTAU plus Cognitive Remediation ProgramTreatment normally received at this clinic that generally includes individual or group sessions and regular urine monitoring PLUS computerized games that focus on learning and decision making.
Primary Outcome Measures
NameTimeMethod
Change in Pre-Post Cognitive Affective Battery: Breath Holdingfrom the week prior to training (pre) to the week after training (post)

Negative emotionality-distress tolerance as measured by the difference between when the participant says they are uncomfortable and when they let go of holding their breath. Measured in seconds (this was natural log-transformed due to skewness for analyses). Positive change indicates improved distress tolerance over time.

Change in Stop Signal Reaction TimeTraining visit 1 through 4 weeks of training

Improved functioning on cognitive-affective battery: Examining Stop Signal reaction time changed across the 4-week training period. A change score was calculated. A negative number indicates better inhibition over time.

Change From Pre-Post in Substance Use4 weeks before First Training Session through the 4-week training period

The cube root of the number of days the participant endorsed using their primary substance. The number of days was submitted to a cube root transformation given skewness and a change score was calculated (post minus pre). A negative number indicated decreased substance use over time.

Change in Pre-Post Cognitive Affective Battery: Delay Discountingfrom the week prior to training (pre) to the week after training (post)

Incentive salience- delay discounting. Five-Trial Adjusting-Delay Discounting Task (Koffarnus \& Bickel, 2014) is a 5-item behavioral assessment used to estimate the extent to which individuals prefer smaller immediate rewards over larger delayed rewards. A discount rate (ln (k)) is calculated for each time the measure is used. Discount rates for the 5- trial delay task were calculated by taking the inverse of the obtained Effective Delay 50 value, which is equivalent to the value of k, when fitted to this singular point. Ln(k) is the natural log of the discount rate. A change score was calculated. Negative change indicates improved decision-making

Change in Pre-Post Cognitive Affective Battery- Negative Urgency Subscale (Part of the Urgency, Premeditation (Lack of), Perseverance (Lack of), Sensation Seeking, Positive Urgency, Impulsive Behavior Scale)from the week prior to training to the week after training

Negative urgency (NU) subscale. The scale score range is 11-44. Higher values indicate stronger agreement with this pathway toward impulsivity. A change score was calculated. A negative number indicates less agreement with negative urgency.

Change in Experimental Performance-Change in Percentage of Risky Choices Under Risk Condition of the Lottery TaskTraining visit 1 through 4 weeks of training

The percent of risky choices per session. This would indicate that the participant selected the lottery option that reflected a riskier bet.

A change score was calculated. A negative number indicates improved decision-making (selecting fewer risky options).

Change in Experimental Performance- Paced Auditory Serial Addition Test (PASAT)from the week prior to training (pre) to the week after training (post)

Estimated change in percentage of trial attempts on round 3 of the PASAT. A positive number reflects more trial attempts in the third round of PASAT.

Change in Experimental Performance- Change in Percentage of Ambiguous Choices Under 24% Ambiguity in Lottery TaskTraining visit 1 through 4 weeks of training

Percent of choices the participant made that reflected selecting the ambiguous option.

A change score was calculated. A negative number reflects improved decision-making (selecting more safe options).

Change in Pre-Post Cognitive Affective Battery: Digit Backwardsfrom the week prior to training (pre) to the week after training (post)

Score on digit backwards. Fourteen strings of varying lengths (2 to 7 digits) are presented. A participant receives a point for each string they correctly repeat backwards. Range 0-14 points. Change score was calculated-positive values indicate improved working memory over time.

Change in Pre-Post Cognitive Affective Battery: Perceived Stress Scalefrom the week prior to training (pre) to the week after training (post)

Negative emotionality-perceived stress. The total score ranges from 0-4. Higher scores indicate a higher level of perceived stress. A change score was calculated. Negative change indicates an improvement (reduction in perceived stress) over time.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Substance Abuse Treatment Center (SATU)

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath